Accurius Therapeutics, Inc.
Lexington, MA
- UEI
- QDZQGEE1TAX3
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 213 East St, Lexington, MA 02420, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Preclinical and IND enabling studies for treatment of advanced lung cancer and other cancers metastatic to lung by… | National Cancer Institute (NIH) | $2,799,998 |
Quick answers
Is Accurius Therapeutics, Inc. registered in SAM.gov?
Yes. Accurius Therapeutics, Inc.'s SAM.gov registration is active through January 30, 2027.
What is Accurius Therapeutics, Inc.'s most recent federal award?
Accurius Therapeutics, Inc.'s most recent federal grant award is Preclinical and IND enabling studies for treatment of advanced lung cancer and other cancers metastatic to lung by… (R44CA287806), from National Cancer Institute (NIH), on September 21, 2023.
On GovTribe
See Accurius Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors